MPIL Corporation Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 20, 2025, 10:51 pm

Competitors of MPIL Corporation Ltd

All Competitor Stocks of MPIL Corporation Ltd

Quarterly Result

Last Updated: August 19, 2025, 1:05 pm

Below is a detailed analysis of the quarterly data for MPIL Corporation Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 0.02 Cr.. The value appears strong and on an upward trend. It has increased from 0.01 Cr. (Mar 2025) to 0.02 Cr., marking an increase of 0.01 Cr..
• For Expenses, as of Jun 2025, the value is 0.16 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 2.64 Cr. (Mar 2025) to 0.16 Cr., marking a decrease of 2.48 Cr..
• For Operating Profit, as of Jun 2025, the value is -0.14 Cr.. The value appears strong and on an upward trend. It has increased from -2.63 Cr. (Mar 2025) to -0.14 Cr., marking an increase of 2.49 Cr..
• For OPM %, as of Jun 2025, the value is -700.00%. The value appears strong and on an upward trend. It has increased from -26,300.00% (Mar 2025) to -700.00%, marking an increase of 25,600.00%.
• For Other Income, as of Jun 2025, the value is 0.36 Cr.. The value appears to be declining and may need further review. It has decreased from 0.37 Cr. (Mar 2025) to 0.36 Cr., marking a decrease of 0.01 Cr..
• For Interest, as of Jun 2025, the value is 0.09 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.09 Cr..
• For Depreciation, as of Jun 2025, the value is 0.01 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.01 Cr..
• For Profit before tax, as of Jun 2025, the value is 0.12 Cr.. The value appears strong and on an upward trend. It has increased from -2.36 Cr. (Mar 2025) to 0.12 Cr., marking an increase of 2.48 Cr..
• For Tax %, as of Jun 2025, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00%.
• For Net Profit, as of Jun 2025, the value is 0.12 Cr.. The value appears strong and on an upward trend. It has increased from -2.36 Cr. (Mar 2025) to 0.12 Cr., marking an increase of 2.48 Cr..
• For EPS in Rs, as of Jun 2025, the value is 2.10. The value appears strong and on an upward trend. It has increased from -41.29 (Mar 2025) to 2.10, marking an increase of 43.39.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: November 15, 2025, 3:03 am

Growth

Last Updated: September 5, 2025, 3:51 pm

Balance Sheet

Last Updated: July 25, 2025, 1:01 pm

Below is a detailed analysis of the balance sheet data for MPIL Corporation Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 0.57 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.57 Cr..
• For Reserves, as of Mar 2025, the value is 13.03 Cr.. The value appears to be declining and may need further review. It has decreased from 15.37 Cr. (Mar 2024) to 13.03 Cr., marking a decrease of 2.34 Cr..
• For Borrowings, as of Mar 2025, the value is 0.22 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 0.27 Cr. (Mar 2024) to 0.22 Cr., marking a decrease of 0.05 Cr..
• For Other Liabilities, as of Mar 2025, the value is 6.09 Cr.. The value appears to be improving (decreasing). It has decreased from 6.17 Cr. (Mar 2024) to 6.09 Cr., marking a decrease of 0.08 Cr..
• For Total Liabilities, as of Mar 2025, the value is 19.91 Cr.. The value appears to be improving (decreasing). It has decreased from 22.38 Cr. (Mar 2024) to 19.91 Cr., marking a decrease of 2.47 Cr..
• For Fixed Assets, as of Mar 2025, the value is 1.57 Cr.. The value appears to be declining and may need further review. It has decreased from 1.63 Cr. (Mar 2024) to 1.57 Cr., marking a decrease of 0.06 Cr..
• For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Investments, as of Mar 2025, the value is 3.89 Cr.. The value appears to be declining and may need further review. It has decreased from 6.18 Cr. (Mar 2024) to 3.89 Cr., marking a decrease of 2.29 Cr..
• For Other Assets, as of Mar 2025, the value is 14.45 Cr.. The value appears to be declining and may need further review. It has decreased from 14.57 Cr. (Mar 2024) to 14.45 Cr., marking a decrease of 0.12 Cr..
• For Total Assets, as of Mar 2025, the value is 19.91 Cr.. The value appears to be declining and may need further review. It has decreased from 22.38 Cr. (Mar 2024) to 19.91 Cr., marking a decrease of 2.47 Cr..

Notably, the Reserves (13.03 Cr.) exceed the Borrowings (0.22 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for MPIL Corporation Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is -40.06. This value is below the healthy minimum of 5. It has decreased from -10.20 (Mar 24) to -40.06, marking a decrease of 29.86.
• For Diluted EPS (Rs.), as of Mar 25, the value is -40.06. This value is below the healthy minimum of 5. It has decreased from -10.20 (Mar 24) to -40.06, marking a decrease of 29.86.
• For Cash EPS (Rs.), as of Mar 25, the value is -39.01. This value is below the healthy minimum of 3. It has decreased from -8.40 (Mar 24) to -39.01, marking a decrease of 30.61.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 237.95. It has decreased from 259.94 (Mar 24) to 237.95, marking a decrease of 21.99.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 237.95. It has decreased from 278.92 (Mar 24) to 237.95, marking a decrease of 40.97.
• For Dividend / Share (Rs.), as of Mar 25, the value is 0.45. This value is below the healthy minimum of 1. It has decreased from 0.90 (Mar 24) to 0.45, marking a decrease of 0.45.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 1.05. It has increased from 0.00 (Mar 24) to 1.05, marking an increase of 1.05.
• For PBDIT / Share (Rs.), as of Mar 25, the value is -32.54. This value is below the healthy minimum of 2. It has decreased from -1.84 (Mar 24) to -32.54, marking a decrease of 30.70.
• For PBIT / Share (Rs.), as of Mar 25, the value is -33.59. This value is below the healthy minimum of 0. It has decreased from -3.63 (Mar 24) to -33.59, marking a decrease of 29.96.
• For PBT / Share (Rs.), as of Mar 25, the value is -40.06. This value is below the healthy minimum of 0. It has decreased from -10.20 (Mar 24) to -40.06, marking a decrease of 29.86.
• For Net Profit / Share (Rs.), as of Mar 25, the value is -40.06. This value is below the healthy minimum of 2. It has decreased from -10.20 (Mar 24) to -40.06, marking a decrease of 29.86.
• For PBDIT Margin (%), as of Mar 25, the value is -3,100.00. This value is below the healthy minimum of 10. It has decreased from 0.00 (Mar 24) to -3,100.00, marking a decrease of 3,100.00.
• For PBIT Margin (%), as of Mar 25, the value is -3,200.00. This value is below the healthy minimum of 10. It has decreased from 0.00 (Mar 24) to -3,200.00, marking a decrease of 3,200.00.
• For PBT Margin (%), as of Mar 25, the value is -3,816.66. This value is below the healthy minimum of 10. It has decreased from 0.00 (Mar 24) to -3,816.66, marking a decrease of 3,816.66.
• For Net Profit Margin (%), as of Mar 25, the value is -3,816.66. This value is below the healthy minimum of 5. It has decreased from 0.00 (Mar 24) to -3,816.66, marking a decrease of 3,816.66.
• For Return on Networth / Equity (%), as of Mar 25, the value is -16.83. This value is below the healthy minimum of 15. It has decreased from -3.92 (Mar 24) to -16.83, marking a decrease of 12.91.
• For Return on Capital Employeed (%), as of Mar 25, the value is -13.89. This value is below the healthy minimum of 10. It has decreased from -1.27 (Mar 24) to -13.89, marking a decrease of 12.62.
• For Return On Assets (%), as of Mar 25, the value is -11.50. This value is below the healthy minimum of 5. It has decreased from -2.60 (Mar 24) to -11.50, marking a decrease of 8.90.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.01. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.01.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.01. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 0.01.
• For Current Ratio (X), as of Mar 25, the value is 0.73. This value is below the healthy minimum of 1.5. It has decreased from 1.10 (Mar 24) to 0.73, marking a decrease of 0.37.
• For Quick Ratio (X), as of Mar 25, the value is 0.73. This value is below the healthy minimum of 1. It has decreased from 1.10 (Mar 24) to 0.73, marking a decrease of 0.37.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has increased from -11.75 (Mar 24) to 0.00, marking an increase of 11.75.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has increased from -14.25 (Mar 24) to 0.00, marking an increase of 14.25.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 111.75 (Mar 24) to 0.00, marking a decrease of 111.75.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 114.25 (Mar 24) to 0.00, marking a decrease of 114.25.
• For Interest Coverage Ratio (X), as of Mar 25, the value is -5.03. This value is below the healthy minimum of 3. It has decreased from -0.27 (Mar 24) to -5.03, marking a decrease of 4.76.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is -5.19. This value is below the healthy minimum of 3. It has decreased from -0.55 (Mar 24) to -5.19, marking a decrease of 4.64.
• For Enterprise Value (Cr.), as of Mar 25, the value is 38.86. It has decreased from 49.09 (Mar 24) to 38.86, marking a decrease of 10.23.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 647.62. This value exceeds the healthy maximum of 3. It has increased from 0.00 (Mar 24) to 647.62, marking an increase of 647.62.
• For EV / EBITDA (X), as of Mar 25, the value is -20.89. This value is below the healthy minimum of 5. It has increased from -467.56 (Mar 24) to -20.89, marking an increase of 446.67.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 644.86. This value exceeds the healthy maximum of 3. It has increased from 0.00 (Mar 24) to 644.86, marking an increase of 644.86.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 111.75 (Mar 24) to 0.00, marking a decrease of 111.75.
• For Price / BV (X), as of Mar 25, the value is 2.84. This value is within the healthy range. It has decreased from 3.29 (Mar 24) to 2.84, marking a decrease of 0.45.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 645.28. This value exceeds the healthy maximum of 3. It has increased from 0.00 (Mar 24) to 645.28, marking an increase of 645.28.
• For EarningsYield, as of Mar 25, the value is -0.05. This value is below the healthy minimum of 5. It has decreased from -0.01 (Mar 24) to -0.05, marking a decrease of 0.04.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness